Timar J, Paterson H
1st Institute of Pathology and Experimental Cancer Research, Semmelweis Medical University, Budapest, Hungary.
Cancer Lett. 1990 Sep;53(2-3):145-50. doi: 10.1016/0304-3835(90)90207-e.
The alterations in the production of proteoglycans in relation to the expression of the malignant phenotype - controlled by the level of expression of activated N-ras gene - was studied in HT1080 human fibrosarcoma cells and in its revertant variants rev.1c and rev.10a. A decreased production of radiolabelled PGs - especially HSPGs - was observed in HT1080 cells, compared to the revertant lines. By immunofluorescence, the HSPG epitopes were localized mainly into the putative endoplasmic reticulum and/or Golgi zone in HT1080 cells, and to the diffuse cytoplasmic and membrane localization in the revertant lines. It is suggested, that the altered expression of PGs represents an important aspect of the transformed phenotype of HT1080 fibrosarcoma cells.
在HT1080人纤维肉瘤细胞及其回复变体rev.1c和rev.10a中,研究了蛋白聚糖产生的变化与恶性表型表达的关系——该恶性表型受活化N-ras基因表达水平的控制。与回复系相比,在HT1080细胞中观察到放射性标记的PGs(尤其是HSPGs)产量降低。通过免疫荧光法,HSPG表位在HT1080细胞中主要定位于假定的内质网和/或高尔基体区,而在回复系中定位于弥漫性细胞质和膜区。有人提出,PGs表达的改变代表了HT1080纤维肉瘤细胞转化表型的一个重要方面。